Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 131,508 | 111,315 | 82,662 | 31,211 | 12,290 |
| Depreciation Amortization | 25,743 | 21,197 | 17,693 | 17,061 | 17,397 |
| Income taxes - deferred | -9,596 | 166 | 8,063 | 81 | -2,739 |
| Accounts receivable | -5,025 | -24,721 | -14,803 | -5,331 | -5,804 |
| Accounts payable and accrued liabilities | 1,454 | 2,173 | 6,254 | 3,926 | 3,142 |
| Other Working Capital | -12,340 | -17,200 | 6,826 | 8,069 | 3,102 |
| Other Operating Activity | 23,463 | 32,765 | 13,610 | 19,761 | 26,808 |
| Operating Cash Flow | $155,207 | $125,695 | $120,305 | $74,778 | $54,196 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -27,152 | -10,038 | -21,701 | -15,165 | -9,218 |
| Net Acquisitions | -11,536 | -7,338 | N/A | N/A | -1,782 |
| Purchase Sale Intangibles | -354 | -317 | -266 | -103 | -209 |
| Other Investing Activity | -2,420 | -2,599 | -1,894 | -1,199 | 16,936 |
| Investing Cash Flow | $-41,108 | $-19,975 | $-23,595 | $-16,364 | $5,936 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 5,000 | 4,516 | 342,000 | 82,000 | 14,962 |
| Debt Repayment | -61,397 | -4,253 | -131,504 | -108,982 | -32,469 |
| Common Stock Issued | 1,167 | 18,454 | 71,353 | 8,215 | 8,487 |
| Common Stock Repurchased | -31,740 | -181,812 | -251,088 | -41,446 | -51,307 |
| Dividend Paid | -27,645 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 11,037 | 28,769 | -86,991 | -488 | 0 |
| Financing Cash Flow | $-103,578 | $-134,326 | $-56,230 | $-60,701 | $-60,327 |
| Beginning Cash Position | 25,617 | 54,223 | 13,743 | 16,030 | 16,225 |
| End Cash Position | 36,138 | 25,617 | 54,223 | 13,743 | 16,030 |
| Net Cash Flow | $10,521 | $-28,606 | $40,480 | $-2,287 | $-195 |
| Free Cash Flow | |||||
| Operating Cash Flow | 155,207 | 125,695 | 120,305 | 74,778 | 54,196 |
| Capital Expenditure | -30,950 | -23,827 | -24,415 | -19,095 | -10,888 |
| Free Cash Flow | 124,257 | 101,868 | 95,890 | 55,683 | 43,308 |